In an embarrassment to the U.K.’s National Health Service, clinical commissioning groups in England accepted hundreds of payments from drug makers and other companies over the past two years that were not publicly disclosed, according to an analysis by BMJ, the medical journal.

Clinical commissioning groups are organizations of local U.K. doctors who issue decisions about hospital care, medicines to be prescribed, and mental health services, among other things. And these groups are overseen by the NHS.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy